Louis Sharon A, Rietze Rodney L, Deleyrolle Loic, Wagey Ravenska E, Thomas Terry E, Eaves Allen C, Reynolds Brent A
StemCell Technologies Inc., Vancouver, British Columbia, Canada.
Stem Cells. 2008 Apr;26(4):988-96. doi: 10.1634/stemcells.2007-0867. Epub 2008 Jan 24.
Advancement in our understanding of the biology of adult stem cells and their therapeutic potential relies heavily on meaningful functional assays that can identify and measure stem cell activity in vivo and in vitro. In the mammalian nervous system, neural stem cells (NSCs) are often studied using a culture system referred to as the neurosphere assay. We previously challenged a central tenet of this assay, that all neurospheres are derived from a NSC, and provided evidence that it overestimates NSC frequency, rendering it inappropriate for quantitation of NSC frequency in relation to NSC regulation. Here we report the development and validation of the neural colony-forming cell assay (NCFCA), which discriminates stem from progenitor cells on the basis of their proliferative potential. We anticipate that the NCFCA will provide additional clarity in discerning the regulation of NSCs, thereby facilitating further advances in the promising application of NSCs for therapeutic use.
我们对成体干细胞生物学及其治疗潜力的理解进展在很大程度上依赖于有意义的功能测定,这些测定能够在体内和体外识别并测量干细胞活性。在哺乳动物神经系统中,神经干细胞(NSCs)常常通过一种称为神经球测定的培养系统来进行研究。我们之前对该测定的一个核心原则提出了质疑,即所有神经球都源自神经干细胞,并提供了证据表明它高估了神经干细胞的频率,使其不适用于定量与神经干细胞调节相关的神经干细胞频率。在此,我们报告神经集落形成细胞测定(NCFCA)的开发与验证,该测定基于干细胞和祖细胞的增殖潜力来区分它们。我们预计,神经集落形成细胞测定将在辨别神经干细胞的调节方面提供更多清晰认识,从而促进神经干细胞在治疗应用这一有前景领域的进一步进展。